This list is based on the watchlists of people on Stock Events who follow GNIIF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. The company offers Etuary for the treatment of idiopathic pulmonary fibrosis. It is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue-associated interstitial lung disease; and in clinical trial pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, the company is involved in developing F351, which is in Phase III clinical trial for the treatment of liver fibrosis; and F573, which is in phase II for the treatment of acute chronic liver failure. Further, it is developing F528, which is in Phase 2 clinical trial for Chronic Obstructive Pulmonary Disease; and F230, which is in clinical trial for Pulmonary Arterial Hypertension. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Show more...
FAQ
What is GNI Group stock price today?▼
The current price of GNIIF is $15.5 USD — it has decreased by -5.89% in the past 24 hours. Watch GNI Group stock price performance more closely on the chart.
What is GNI Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GNI Group stocks are traded under the ticker GNIIF.
What is GNI Group market cap?▼
Today GNI Group has the market capitalization of 783.76M
When is the next GNI Group earnings date?▼
GNI Group is going to release the next earnings report on May 18, 2026.
What were GNI Group earnings last quarter?▼
GNIIF earnings for the last quarter are -0.48 USD per share, whereas the estimation was 1.43 USD resulting in a -133.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GNI Group revenue for the last year?▼
GNI Group revenue for the last year amounts to 311.32M USD.
What is GNI Group net income for the last year?▼
GNIIF net income for the last year is 15.42M USD.
When did GNI Group complete a stock split?▼
The last stock split for GNI Group was on September 02, 2019 with a ratio of 3:1.
Where is GNI Group headquartered?▼
GNI Group is headquartered in Tokyo, JP.